Scientists Just Reversed About 80% of Aging in Elderly Mice in a Single Month — and They Did It by Boosting One Protein

Why It Matters

This demonstrates that key epigenetic features of aging are not irreversible, opening new avenues for targeted anti‑aging therapies, but substantial work is needed before any human application.

Key Takeaways

• SIRT6 boost reverses ~80% liver chromatin changes in 24‑month mice
• One‑month viral vector treatment restores youthful gene expression and reduces inflammation
• Lifelong SIRT6 overexpression protects ~95% of age‑related chromatin alterations
• Study limited to male mouse liver; human translation remains distant
• Finding proves aging‑related chromatin patterns are reversible, not immutable

Pulse Analysis

The quest to slow or reverse aging has long centered on sirtuin proteins, a family that regulates DNA repair, metabolism and chromatin structure. SIRT6, a member of this family, has attracted attention for its role in maintaining genome stability and metabolic health. By elevating SIRT6 levels, the Bar‑Ilan team tapped into a natural cellular pathway that governs how tightly DNA is packaged, a factor that drifts with age and influences which genes are active.

In the study, researchers used two approaches: mice genetically engineered to overexpress SIRT6 throughout life, and 24‑month‑old mice that received a liver‑targeted AAV8 viral vector delivering the SIRT6 gene. Within a single month, the viral‑treated mice showed an 80% reversal of age‑associated chromatin accessibility shifts, accompanied by reduced interferon‑alpha inflammation and a re‑alignment of metabolic gene programs toward a youthful profile. Multi‑omics analyses—ATAC‑seq, RNA‑seq and methylome profiling—provided a comprehensive view, confirming that the epigenetic reset translated into functional gene expression changes.

Despite the striking molecular reset, the findings are bounded by several constraints. The work focused exclusively on male mouse liver, leaving open questions about sex differences and tissue‑specific effects. Translating a mouse‑optimized viral vector to humans would require extensive safety testing and validation that human hepatocytes respond similarly. Nonetheless, the proof that age‑linked chromatin alterations can be rapidly reversed reshapes the scientific narrative around epigenetic rigidity and offers a concrete target for future drug‑development pipelines seeking to modulate aging pathways.